YAKUODO HOLDINGS Co., Ltd. (7679.T)
JPY 1977.0
(-0.05%)
JPY 1977.0
(-0.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.21 Billion JPY | 11.82% |
| 2022 | 4.66 Billion JPY | 15.26% |
| 2021 | 4.04 Billion JPY | -18.75% |
| 2020 | 4.97 Billion JPY | 27.13% |
| 2019 | 3.91 Billion JPY | 0.69% |
| 2018 | 3.88 Billion JPY | 10.18% |
| 2017 | 3.52 Billion JPY | 10.73% |
| 2016 | 3.18 Billion JPY | 20.14% |
| 2015 | 2.65 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.4 Billion JPY | 154.81% |
| 2024 Q2 | 1.77 Billion JPY | 26.57% |
| 2023 Q2 | 1.91 Billion JPY | 42.15% |
| 2023 Q4 | 551 Million JPY | -60.36% |
| 2023 FY | 5.21 Billion JPY | 11.82% |
| 2023 Q3 | 1.39 Billion JPY | -27.57% |
| 2023 Q1 | 1.35 Billion JPY | 115.65% |
| 2022 Q1 | 1.22 Billion JPY | 153.21% |
| 2022 FY | 4.66 Billion JPY | 15.26% |
| 2022 Q4 | 626 Million JPY | -48.35% |
| 2022 Q3 | 1.21 Billion JPY | -24.2% |
| 2022 Q2 | 1.59 Billion JPY | 30.74% |
| 2021 Q1 | 1.23 Billion JPY | 88.15% |
| 2021 Q2 | 1.4 Billion JPY | 13.81% |
| 2021 Q3 | 913 Million JPY | -35.2% |
| 2021 FY | 4.04 Billion JPY | -18.75% |
| 2021 Q4 | 483 Million JPY | -47.1% |
| 2020 Q4 | 658 Million JPY | -47.82% |
| 2020 Q2 | 1.67 Billion JPY | 20.4% |
| 2020 Q1 | 1.38 Billion JPY | 40.1% |
| 2020 FY | 4.97 Billion JPY | 27.13% |
| 2020 Q3 | 1.26 Billion JPY | -24.49% |
| 2019 Q4 | 990 Million JPY | 0.0% |
| 2019 Q1 | 915 Million JPY | 2.46% |
| 2019 FY | 3.91 Billion JPY | 0.69% |
| 2018 Q1 | 900 Million JPY | 0.0% |
| 2018 FY | 3.88 Billion JPY | 10.18% |
| 2018 Q4 | 893 Million JPY | -0.89% |
| 2018 Q3 | 901 Million JPY | -24.48% |
| 2018 Q2 | 1.19 Billion JPY | 32.56% |
| 2017 FY | 3.52 Billion JPY | 10.73% |
| 2016 FY | 3.18 Billion JPY | 20.14% |
| 2015 FY | 2.65 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HEARTSEED INC | -1.45 Billion JPY | 457.012% |
| Cawachi Limited | 7.6 Billion JPY | 31.443% |
| Pharmarise Holdings Corporation | 916 Million JPY | -468.886% |
| Qol Holdings Co., Ltd. | 8.32 Billion JPY | 37.405% |
| MatsukiyoCocokara & Co. | 75.7 Billion JPY | 93.117% |
| Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 87.946% |
| Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 74.237% |
| NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 43.012% |
| COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 83.458% |
| Tsuruha Holdings Inc. | 49.2 Billion JPY | 89.41% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | -154.941% |
| Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | -276.245% |
| Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 71.937% |
| Medical System Network Co., Ltd. | 3.83 Billion JPY | -35.986% |
| Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | -38.812% |
| Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 85.771% |
| Astena Holdings Co., Ltd. | 1.12 Billion JPY | -361.93% |
| Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 42.203% |
| Ain Holdings Inc. | 20.43 Billion JPY | 74.496% |
| Sundrug Co.,Ltd. | 40.99 Billion JPY | 87.289% |